The HIV pipeline

descriptionPublicationkeyboard_double_arrow_right Article 22 Aug 2014 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 13, pages 649-650 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Angel, Wong;

doi: 10.1038/nrd4364

pmid: 25145593

The HIV pipeline

- Summary
- Subjects
- Metrics

Abstract

The developmental pipeline of HIV antiretroviral therapies is large and diverse, spanning a number of different drug classes. This article provides an overview of the agents in development, including combination therapies, and an analysis of the market for current and future HIV treatments.

Keywords

AIDS Vaccines, Clinical Trials as Topic, Anti-HIV Agents, HIV Infections, Anti-Retroviral Agents, Drug Discovery, Animals, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%